Rights Issue period closes today; issue of up to Rs.12,794 millions approved at Rs.750 per share
Natco Pharma has informed the exchanges that its Rights Issue period closes today, Thursday, October 22, 2026.
By ScoutQuest · · 2 min read
- Issue Price per Share
- Rs.750/- each
- Face Value per Share
- Rs.2/-
- Issue Size
- up to Rs.12,794 millions
What the update says
- The Board of Directors, at its meeting held on 25th September, 2026, approved the terms of an issuance of equity shares of the company.
- The shares are of face value of Rs.2/- each, issued for cash at a price of Rs.750/- each.
- The route is a Rights Issue, for an amount aggregating up to Rs.12,794 millions.
- The Issue opened on Monday, October 12, 2026.
- The Issue closes today, i.e. Thursday, October 22, 2026.
- The intimation has been shared with BSE (Scrip Code: 524816) and NSE (Symbol: NATCOPHARM).
What a rights issue is
A rights issue gives existing shareholders the first right to buy new shares, usually in a fixed proportion to the shares they already hold. The price per share and the ratio are fixed in advance, and eligible shareholders get a limited window to apply.
Why this notice matters
This update is about the closing of that window. It signals the end of the period in which eligible shareholders could apply for the new shares, and the start of the process where the company finalises allotment of the shares applied for.
The numbers in the update
- Face value per share: Rs.2/-
- Issue price per share: Rs.750/-
- Total Issue size: up to Rs.12,794 millions
- Issue window: opened October 12, 2026, closed October 22, 2026
Points to keep in mind
- The issue price of Rs.750/- per share is the price at which the new shares are being offered; the face value is Rs.2/-.
- The amount of up to Rs.12,794 millions is the size of the Issue as stated in the update.
- Applications are not open after today, which is the closure date mentioned in the notice.
What to watch next
After the Issue period ends, the company's disclosures around the basis of allotment and the allotment of shares are the natural next steps to track.
Also from Natco Pharma
Allotment of ~1.71 crore equity shares at ₹750 each under rights issue
23 Oct 2026
Carboplatin Injection, generic of Paraplatin, launched in the U.S. market
19 Oct 2026
Natco Pharma in focus after Abu Dhabi Investment Authority acquired 1.73 lakh shares
19 Oct 2026
More numbers
- Face value per equity shareRs.2/-
- Issue price per equity share (Rights Issue)Rs.750/-
- Rights Issue sizeRs.12,794 millions
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.